Cargando…
Oculocutaneous albinism and bleeding diathesis due to a novel deletion in the HPS3 gene
Hermansky–Pudlak syndrome (HPS) is a group of rare autosomal recessive disorders characterized by oculocutaneous albinism (OCA) and bleeding diathesis. To date, 11 HPS types have been reported (HPS-1 to HPS-11), each defined by disease-causing variants in specific genes. Variants in the HPS1 gene we...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420964/ https://www.ncbi.nlm.nih.gov/pubmed/36046236 http://dx.doi.org/10.3389/fgene.2022.936064 |
_version_ | 1784777487853551616 |
---|---|
author | Marek-Yagel, Dina Abudi-Sinreich, Shachar Macarov, Michal Veber, Alvit Shalva, Nechama Philosoph, Amit Mary Pode-Shakked, Ben Malicdan, May Christine V. Anikster, Yair |
author_facet | Marek-Yagel, Dina Abudi-Sinreich, Shachar Macarov, Michal Veber, Alvit Shalva, Nechama Philosoph, Amit Mary Pode-Shakked, Ben Malicdan, May Christine V. Anikster, Yair |
author_sort | Marek-Yagel, Dina |
collection | PubMed |
description | Hermansky–Pudlak syndrome (HPS) is a group of rare autosomal recessive disorders characterized by oculocutaneous albinism (OCA) and bleeding diathesis. To date, 11 HPS types have been reported (HPS-1 to HPS-11), each defined by disease-causing variants in specific genes. Variants in the HPS1 gene were found in approximately 15% of HPS patients, most of whom harbor the Puerto Rican founder mutation. In this study, we report six affected individuals from three nonconsanguineous families of Ashkenazi Jewish descent, who presented with OCA and multiple ecchymoses and had normal platelet number and size. Linkage analysis indicated complete segregation to HPS3. Sequencing of the whole coding region and the intron boundaries of HPS3 revealed a heterozygous c.1163+1G>A variant in all six patients. Long-range PCR amplification revealed that all affected individuals also carry a 14,761bp deletion that includes the 5′UTR and exon 1 of HPS3, encompassing regions with long interspersed nuclear elements. The frequency of the c.1163+1G>A splice site variant was found to be 1:200 in the Ashkenazi Jewish population, whereas the large deletion was not detected in 300 Ashkenazi Jewish controls. These results present a novel HPS3 deletion mutation and suggest that the prevalence of HPS-3 in Ashkenazi Jews is more common than previously thought. |
format | Online Article Text |
id | pubmed-9420964 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-94209642022-08-30 Oculocutaneous albinism and bleeding diathesis due to a novel deletion in the HPS3 gene Marek-Yagel, Dina Abudi-Sinreich, Shachar Macarov, Michal Veber, Alvit Shalva, Nechama Philosoph, Amit Mary Pode-Shakked, Ben Malicdan, May Christine V. Anikster, Yair Front Genet Genetics Hermansky–Pudlak syndrome (HPS) is a group of rare autosomal recessive disorders characterized by oculocutaneous albinism (OCA) and bleeding diathesis. To date, 11 HPS types have been reported (HPS-1 to HPS-11), each defined by disease-causing variants in specific genes. Variants in the HPS1 gene were found in approximately 15% of HPS patients, most of whom harbor the Puerto Rican founder mutation. In this study, we report six affected individuals from three nonconsanguineous families of Ashkenazi Jewish descent, who presented with OCA and multiple ecchymoses and had normal platelet number and size. Linkage analysis indicated complete segregation to HPS3. Sequencing of the whole coding region and the intron boundaries of HPS3 revealed a heterozygous c.1163+1G>A variant in all six patients. Long-range PCR amplification revealed that all affected individuals also carry a 14,761bp deletion that includes the 5′UTR and exon 1 of HPS3, encompassing regions with long interspersed nuclear elements. The frequency of the c.1163+1G>A splice site variant was found to be 1:200 in the Ashkenazi Jewish population, whereas the large deletion was not detected in 300 Ashkenazi Jewish controls. These results present a novel HPS3 deletion mutation and suggest that the prevalence of HPS-3 in Ashkenazi Jews is more common than previously thought. Frontiers Media S.A. 2022-08-15 /pmc/articles/PMC9420964/ /pubmed/36046236 http://dx.doi.org/10.3389/fgene.2022.936064 Text en Copyright © 2022 Marek-Yagel, Abudi-Sinreich, Macarov, Veber, Shalva, Philosoph, Pode-Shakked, Malicdan and Anikster. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Genetics Marek-Yagel, Dina Abudi-Sinreich, Shachar Macarov, Michal Veber, Alvit Shalva, Nechama Philosoph, Amit Mary Pode-Shakked, Ben Malicdan, May Christine V. Anikster, Yair Oculocutaneous albinism and bleeding diathesis due to a novel deletion in the HPS3 gene |
title | Oculocutaneous albinism and bleeding diathesis due to a novel deletion in the HPS3 gene |
title_full | Oculocutaneous albinism and bleeding diathesis due to a novel deletion in the HPS3 gene |
title_fullStr | Oculocutaneous albinism and bleeding diathesis due to a novel deletion in the HPS3 gene |
title_full_unstemmed | Oculocutaneous albinism and bleeding diathesis due to a novel deletion in the HPS3 gene |
title_short | Oculocutaneous albinism and bleeding diathesis due to a novel deletion in the HPS3 gene |
title_sort | oculocutaneous albinism and bleeding diathesis due to a novel deletion in the hps3 gene |
topic | Genetics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420964/ https://www.ncbi.nlm.nih.gov/pubmed/36046236 http://dx.doi.org/10.3389/fgene.2022.936064 |
work_keys_str_mv | AT marekyageldina oculocutaneousalbinismandbleedingdiathesisduetoanoveldeletioninthehps3gene AT abudisinreichshachar oculocutaneousalbinismandbleedingdiathesisduetoanoveldeletioninthehps3gene AT macarovmichal oculocutaneousalbinismandbleedingdiathesisduetoanoveldeletioninthehps3gene AT veberalvit oculocutaneousalbinismandbleedingdiathesisduetoanoveldeletioninthehps3gene AT shalvanechama oculocutaneousalbinismandbleedingdiathesisduetoanoveldeletioninthehps3gene AT philosophamitmary oculocutaneousalbinismandbleedingdiathesisduetoanoveldeletioninthehps3gene AT podeshakkedben oculocutaneousalbinismandbleedingdiathesisduetoanoveldeletioninthehps3gene AT malicdanmaychristinev oculocutaneousalbinismandbleedingdiathesisduetoanoveldeletioninthehps3gene AT aniksteryair oculocutaneousalbinismandbleedingdiathesisduetoanoveldeletioninthehps3gene |